Business Wire

QUANTA-CLOUD-TECHNOLOGY

24.5.2022 06:02:09 CEST | Business Wire | Press release

Share
QCT Announces Support of NVIDIA Grace CPU Superchips for Use in HPC and AI Applications

Quanta Cloud Technology (QCT), a global data center solution provider, today announced new servers that will support the NVIDIA Grace™ CPU Superchip and Grace™ Hopper™ Superchip . QCT is incorporating the NVIDIA Grace™ CPU, striving for the highest performance, memory bandwidth, energy efficiency and configurability that is ready for the modern data center and addresses the most demanding artificial intelligence (AI), high-performance computing (HPC), data analytics, digital twins, cloud gaming, and hyperscale computing applications.

Breakthrough CPU for the Modern Data Center

The NVIDIA Grace CPU Superchip is a breakthrough processor designed for the modern data center, providing the highest performance and twice the memory bandwidth and energy-efficiency compared to today’s leading server processors. The NVIDIA Grace CPU Superchip can be used standalone or with NVIDIA’s industry-leading GPU and BlueField® data processing unit (DPU) building blocks. The Grace Hopper Superchip pairs an NVIDIA Grace CPU with an NVIDIA Hopper architecture-based GPU. The integrated module is designed to serve HPC and giant-scale AI applications. The NVIDIA Grace Hopper Superchip will enable up to 10x higher performance in a variety of configurations for applications running terabytes of data, enabling scientists and researchers to reach unprecedented solutions to the world’s most complex problems.

“As a leading cloud enabler, QCT is committed to being a critical enabler for AI and HPC applications for the modern data center,” said Mike Yang, President of QCT. “We are thrilled to broaden our compute portfolio with the NVIDIA Grace CPU Superchip and Grace Hopper Superchip. As we are seeing a rise in the multitude of AI applications, QCT works closely with NVIDIA to ensure our clients can benefit from the latest and greatest CPU, GPU and networking technologies.”

QCT will add the new NVIDIA Grace CPU Superchip and Grace Hopper Superchip to its extensive server portfolio to deliver unprecedented accelerated computing. Designed to interface with the latest PCIe Gen5 protocol, this will be the fastest communication to enable optimal connectivity with the highest-performing GPUs, and the fastest networking with up to 400 gigabits per second (Gb/s) Ethernet or NVIDIA Quantum-2 400Gb/s InfiniBand with NVIDIA ConnectX®-7 smart network interface cards (SmartNICs) and BlueField-3 DPUs to provide best-in-class acceleration for secure HPC and AI workloads. These new QCT server systems will be released next year and will also support NVIDIA’s computing software stacks, including NVIDIA HPC, NVIDIA AI, Omniverse and NVIDIA RTX.

Follow QCT on Facebook and Twitter to receive the latest news and announcements.

About QCT

QCT is a global data center solution provider that combines the efficiency of hyperscale hardware with infrastructure software from a diversity of industry leaders to solve next-generation data center design and operational challenges. QCT serves cloud service providers, telecoms and enterprises running public, hybrid and private clouds. The parent of QCT is Quanta Computer, Inc., a Fortune Global 500 corporation. www.qct.io

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration10.8.2026 12:00:00 CEST | Press release

Clinical collaboration enables novel combinations of select BeOne oncology assets with four Revolution Medicines clinical-stage RAS(ON) inhibitors for RAS-addicted cancersRegional rights agreement provides BeOne with exclusive development and commercialization rights to four Revolution Medicines clinical assets in select Asian markets BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution Medicines’ four clinical RAS(ON) inhibitors, and a separate regional rights agreement granting BeOne exclusive development and commercialization rights to these Revolution Medicines assets in select Asian markets. Clinical

OpenGate Capital to Acquire Maersk Training, the Global Safety Training and Gas-Safety Services Business of Maersk10.8.2026 08:00:00 CEST | Press release

OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has signed a definitive agreement to acquire Maersk Training and its subsidiary Maersk H2S Safety Services. The company, a provider of global safety training and gas safety services, is being carved out from A.P. Møller - Mærsk A/S (MAERSK A:CPH), a listed integrated logistics company. Headquartered in Svendborg, Denmark, Maersk Training is a leading global provider of essential safety services that operates through two complementary business segments. The first segment, Maersk H2S Safety Services, is a specialist provider of outsourced hydrogen sulphide and Health, Safety and Environment safety services, which include onsite supervision, monitoring and safety equipment maintenance for customers in high-risk operating environments. The second segment, Training Business, is a global provider of safety training, competency development and simulation, delivered through instructor led, digital and virtual

Ant International’s Bettr Partners with Muslim Pro to Introduce Umrah Financing Service in Malaysia10.8.2026 05:49:00 CEST | Press release

Bettr, a leading provider of inclusive and embedded finance and fintech solutions under Ant International, today announced its partnership with Muslim Pro, a popular Islamic lifestyle app serving over 190 million downloads worldwide, to launch an Umrah financing solution in Malaysia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260809780047/en/ Ant International's Bettr and Muslim Pro launch an Umrah financing solution in Malaysia to help families better manage their cash flow and spread pilgrimage costs responsibly. The solution is designed for eligible Muslims who have the means to undertake the pilgrimage but prefer to spread its cost over time. This flexibility enables individuals and families to manage their cash flow responsibly, maintain regular savings and preserve sufficient liquidity for emergencies and other financial obligations. The launch marks a significant milestone in Bettr’s Islamic finance initiative and

ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings7.8.2026 19:48:00 CEST | Press release

An ICC Arbitral Tribunal has awarded AOP Orphan Pharmaceuticals GmbH (“AOP Health”) a total of about EUR 112 Mio in a quantum award issued in the ongoing arbitration proceedings with PharmaEssentia Corp. (“PharmaEssentia”) concerning BESREMi® (ropeginterferon alfa-2b). The award quantifies AOP Health’s damage claims for PharmaEssentia’s intentional breaches at ca. EUR 82 Mio. It also awards AOP Health ca. EUR 31 Mio plus interest as reimbursement for AOP Health overpayments made to PharmaEssentia as a result of excessive pricing in the years 2019-2022. The Tribunal thereby confirmed that PharmaEssentia has been overcharging AOP Health by up to 900% over these years. The Tribunal affirmed AOP Health's valid set-off of the profit-sharing payments amount owed to PharmaEssentia of approximately EUR 17 Mio against AOP Health's substantially exceeding damages claims. This means that AOP Health shall not make any payment to PharmaEssentia. Interest on AOP Health’s claims will continue to accr

Coulson Aviation Canada Acquires 10 Former RCAF Hercules, Doubling C-130H Fleet7.8.2026 19:16:00 CEST | Press release

Canadian-led expansion will build the world’s largest and most capable C-130 airtanker fleet Coulson Aviation Canada, the Canadian division of Coulson Aviation, has acquired 10 former Royal Canadian Air Force CC-130H Hercules aircraft from the Government of Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260807019094/en/ Britton Coulson, left, and Wayne Coulson stand in front of one of 10 former Royal Canadian Air Force CC-130H Hercules aircraft recently acquired by Coulson Aviation from the Government of Canada. At right is a Coulson C-130H outfitted for aerial firefighting with the company’s proprietary RADS-XXL retardant delivery system, capable of carrying up to 4,000 U.S. gallons, or more than 15,000 litres, of water or fire retardant. The acquisition doubles Coulson’s global C-130H fleet to 20 aircraft, expanding its capacity to build the world’s largest C-130 airtanker fleet. The acquisition doubles Coulson’s g

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye